Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial - Liposomal Bupivacaine Versus Standard Bupivacaine

NCT03508830 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03508830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03508830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial - Liposomal Bupivacaine Versus Standard Bupivacaine
Lead sponsor
University of California, San Francisco
Phase
Phase 3
Overall status
Completed
Start date
December 30, 2018
Completion date
January 30, 2021
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use, postoperative pain, thoracic diseases